175 related articles for article (PubMed ID: 33322063)
1. A 12-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial for Evaluation of the Efficacy and Safety of DKB114 on Reduction of Uric Acid in Serum.
Park YH; Kim DH; Lee JS; Jeong HI; Lee KW; Kang TH
Nutrients; 2020 Dec; 12(12):. PubMed ID: 33322063
[TBL] [Abstract][Full Text] [Related]
2. DKB114, A Mixture of
Lee YS; Kim SH; Yuk HJ; Kim DS
Nutrients; 2018 Sep; 10(10):. PubMed ID: 30274153
[No Abstract] [Full Text] [Related]
3. Effects of
Lee S; Han EH; Lee SH; Lim MK; Kim CO; Kang S
J Med Food; 2020 May; 23(5):508-514. PubMed ID: 32150484
[No Abstract] [Full Text] [Related]
4. Serum Uric Acid-Lowering Effects of Combined Glycine and Tryptophan Treatments in Subjects with Mild Hyperuricemia: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study.
Oshima S; Shiiya S; Nakamura Y
Nutrients; 2019 Mar; 11(3):. PubMed ID: 30845731
[TBL] [Abstract][Full Text] [Related]
5. Placebo-controlled double-blind dose-response study of the non-purine-selective xanthine oxidase inhibitor febuxostat (TMX-67) in patients with hyperuricemia (including gout patients) in japan: late phase 2 clinical study.
Kamatani N; Fujimori S; Hada T; Hosoya T; Kohri K; Nakamura T; Ueda T; Yamamoto T; Yamanaka H; Matsuzawa Y
J Clin Rheumatol; 2011 Jun; 17(4 Suppl 2):S35-43. PubMed ID: 21654268
[TBL] [Abstract][Full Text] [Related]
6. Acupuncture for serum uric acid in patients with asymptomatic hyperuricemia: A randomized, double-blind, placebo-controlled trial.
Huang Y; Meng J; Sun B; Xiang T; Zhou X; Xu B; Wu Y; Chen Z; Zhang S
Int J Cardiol; 2017 Apr; 232():227-232. PubMed ID: 28087178
[TBL] [Abstract][Full Text] [Related]
7. Tuna extract reduces serum uric acid in gout-free subjects with insignificantly high serum uric acid: A randomized controlled trial.
Kubomura D; Yamada M; Masui A
Biomed Rep; 2016 Aug; 5(2):254-258. PubMed ID: 27446553
[TBL] [Abstract][Full Text] [Related]
8. A randomized, double-blind, positive-controlled, prospective, dose-response clinical study to evaluate the efficacy and tolerability of an aqueous extract of Terminalia bellerica in lowering uric acid and creatinine levels in chronic kidney disease subjects with hyperuricemia.
Pingali U; Nutalapati C; Koilagundla N; Taduri G
BMC Complement Med Ther; 2020 Sep; 20(1):281. PubMed ID: 32933504
[TBL] [Abstract][Full Text] [Related]
9. Clinical efficacy and safety of dotinurad, a novel selective urate reabsorption inhibitor, in Japanese hyperuricemic patients with or without gout: randomized, multicenter, double-blind, placebo-controlled, parallel-group, confirmatory phase 2 study.
Hosoya T; Sano T; Sasaki T; Fushimi M; Ohashi T
Clin Exp Nephrol; 2020 Mar; 24(Suppl 1):53-61. PubMed ID: 31792640
[TBL] [Abstract][Full Text] [Related]
10. Placebo-controlled, double-blind study of the non-purine-selective xanthine oxidase inhibitor Febuxostat (TMX-67) in patients with hyperuricemia including those with gout in Japan: phase 3 clinical study.
Kamatani N; Fujimori S; Hada T; Hosoya T; Kohri K; Nakamura T; Ueda T; Yamamoto T; Yamanaka H; Matsuzawa Y
J Clin Rheumatol; 2011 Jun; 17(4 Suppl 2):S19-26. PubMed ID: 21654266
[TBL] [Abstract][Full Text] [Related]
11. Clinical efficacy and safety of dotinurad, a novel selective urate reabsorption inhibitor, in Japanese hyperuricemic patients with or without gout: an exploratory, randomized, multicenter, double-blind, placebo-controlled, parallel-group early phase 2 study.
Hosoya T; Sano T; Sasaki T; Fushimi M; Ohashi T
Clin Exp Nephrol; 2020 Mar; 24(Suppl 1):44-52. PubMed ID: 31754882
[TBL] [Abstract][Full Text] [Related]
12. Effects of a fermented barley extract on subjects with slightly high serum uric acid or mild hyperuricemia.
Hokazono H; Omori T; Yamamoto T; Akaoka I; Ono K
Biosci Biotechnol Biochem; 2010; 74(4):828-34. PubMed ID: 20378966
[TBL] [Abstract][Full Text] [Related]
13. Effect of Febuxostat on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension: A Phase 2 Randomized Placebo-Controlled Study.
Gunawardhana L; McLean L; Punzi HA; Hunt B; Palmer RN; Whelton A; Feig DI
J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29102979
[TBL] [Abstract][Full Text] [Related]
14. Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial.
Schumacher HR; Becker MA; Wortmann RL; Macdonald PA; Hunt B; Streit J; Lademacher C; Joseph-Ridge N
Arthritis Rheum; 2008 Nov; 59(11):1540-8. PubMed ID: 18975369
[TBL] [Abstract][Full Text] [Related]
15. Effect of vitamin C supplementation on serum uric acid in patients undergoing hemodialysis: a randomized controlled trial.
Biniaz V; Tayebi A; Ebadi A; Sadeghi Shermeh M; Einollahi B
Iran J Kidney Dis; 2014 Sep; 8(5):401-7. PubMed ID: 25194408
[TBL] [Abstract][Full Text] [Related]
16. Febuxostat does not delay progression of carotid atherosclerosis in patients with asymptomatic hyperuricemia: A randomized, controlled trial.
Tanaka A; Taguchi I; Teragawa H; Ishizaka N; Kanzaki Y; Tomiyama H; Sata M; Sezai A; Eguchi K; Kato T; Toyoda S; Ishibashi R; Kario K; Ishizu T; Ueda S; Maemura K; Higashi Y; Yamada H; Ohishi M; Yokote K; Murohara T; Oyama JI; Node K;
PLoS Med; 2020 Apr; 17(4):e1003095. PubMed ID: 32320401
[TBL] [Abstract][Full Text] [Related]
17. Febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase: a twenty-eight-day, multicenter, phase II, randomized, double-blind, placebo-controlled, dose-response clinical trial examining safety and efficacy in patients with gout.
Becker MA; Schumacher HR; Wortmann RL; MacDonald PA; Palo WA; Eustace D; Vernillet L; Joseph-Ridge N
Arthritis Rheum; 2005 Mar; 52(3):916-23. PubMed ID: 15751090
[TBL] [Abstract][Full Text] [Related]
18. Effects of a Novel Fixed Combination of Nutraceuticals on Serum Uric Acid Concentrations and the Lipid Profile in Asymptomatic Hyperuricemic Patients : Results from the PICONZ-UA Study.
Rozza F; Trimarco V; Izzo R; Grassi D; Ferri C
High Blood Press Cardiovasc Prev; 2016 Dec; 23(4):381-386. PubMed ID: 27644242
[TBL] [Abstract][Full Text] [Related]
19. Effect of Inositol Hexaphosphate (IP
Ikenaga T; Kakumoto K; Kohda N; Yamamoto T
Plant Foods Hum Nutr; 2019 Sep; 74(3):316-321. PubMed ID: 31119466
[TBL] [Abstract][Full Text] [Related]
20. Effect of Uric Acid-Lowering Agents on Endothelial Function: A Randomized, Double-Blind, Placebo-Controlled Trial.
Borgi L; McMullan C; Wohlhueter A; Curhan GC; Fisher ND; Forman JP
Hypertension; 2017 Feb; 69(2):243-248. PubMed ID: 28028194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
